Haes-Steril 10.00% Infusion 500 ml

Frequently asked questions

• Onset of action

  The effect of this medicine can be observed within 30 minutes of administration of the dose.

• Duration of Effect

  The effect of this medicine lasts for an average duration of 6 to 36 hours.

• Safe with Alchohol?

  Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

• Is it habit forming?

  No habit-forming tendencies were reported.

• Usage in pregnancy?

  This medicine is not recommended for use in pregnant women unless absolutely necessary. Your doctor will determine the appropriate course after evaluating all the risks and benefits associated with the use of this medicine.

• Usage while breast-feeding?

  This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor will determine the appropriate course after evaluating all the risks and benefits associated with the use of this medicine. If the medicine is used, close monitoring of the infant for any undesired side effects is necessary.

• Allergy

  This medicine is not recommended for use if you have a known allergy to Haes-Steril 10.00% Infusion 500 ml or any other related compounds.

• Congestive Heart Failure

  This medicine is not recommended for use in patients suffering severe congestive heart failure due to the increased risk of worsening of the patient's condition.

• Bleeding disorder

  This medicine is not recommended for use in patients with severe bleeding disorders due to the increased risk of worsening of the patient's condition.

• Severe kidney impairment

  This medicine is not recommended for use in patients with severe kidney impairment due to the increased risk of worsening of the patient's condition.

• Fluid overload

  This medicine is not recommended for use in patients with fluid overload due to the increased risk of worsening of the patient's condition.

• Hypernatremia

  This medicine is not recommended for use in patients with severe hypernatremia (increased blood sodium levels) due to the increased risk of worsening of the patient's condition.

• Pregnancy

  This medicine is not recommended for use in pregnant women unless absolutely necessary. Your doctor will determine the appropriate course after evaluating all the risks and benefits associated with the use of this medicine.

• Breast-feeding

  This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor will determine the appropriate course after evaluating all the risks and benefits associated with the use of this medicine. If the medicine is used, close monitoring of the infant for any undesired side effects is necessary.

• Kidney diseases

  This medicine should be used with caution in patients with kidney diseases due to the increased risk of worsening of the patient's condition. Close monitoring of the kidney function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative might be required in some cases based on the clinical condition.

• Hypersensitivity reactions

  Severe hypersensitivity reactions have been reported with this medicine, which may progress to severe anaphylaxis. In such cases, immediate discontinuation of the therapy is required.

• Coagulation abnormalities

  Monitoring of coagulation parameters and hematocrit are necessary if comparatively large volumes are to be replaced. Care must be taken to ensure adequate substitution of other blood constituents (coagulation factors, electrolytes, platelets, and erythrocytes) along with Volulyte 6% Infusion 500ml to reduce the risk of significant adverse effects.

• Electrolyte imbalances

  Regular monitoring of electrolyte status may be required during the administration of this medicine due to the increased risk of electrolyte imbalances. Appropriate corrective or preventive measures may be necessary in some cases based on the patient's clinical condition.

• Liver diseases

  This medicine should be used with caution in patients with a history of liver diseases due to the increased risk of worsening of the patient's condition.. Close monitoring of the liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative might be required in some cases based on the clinical condition.

• Other medicines

  Volulyte 6% Infusion 500ml may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.

This medicine will be administered by a qualified health care professional in the clinical/hospital setting. Inform the doctor if you have a known allergy to this medicine. Follow all the instructions given by your doctor. Report all your current medicines as well as your medical conditions to the doctor before receiving therapy with this medicine.

• Usage does not depend on food timings
• To be taken as instructed by doctor
• Effect on sleep is not established

• pubchem - Hydroxyethyl starch [Internet]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Hydroxyethyl_starch [cited 12/14/20]. 2020-12-12
• drugbank - Hydroxyethyl Starch [Internet]. Available from: https://go.drugbank.com/drugs/DB09106 [cited 12/14/20]. December 12, 2020